Private company

BLOOMIOS, INC.

Last updated Oct 18, 2026.

Overview

  • IndustryMedicinal Chemicals & Botanical Products
  • Business address701 Anacapa Street, Suite C, Santa Barbara, Ca 931012
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

36.7%Gross margin3
-68.1%Operating margin3
-226.7%Net margin4
-28.4%Revenue growth, 20223

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue60¢$3.8M
  • Selling, general and admin24¢$1.5M
  • Interest15¢$965.9K

Out of $6.1M in revenue.34 The company lost money this year.

Financial statements

Revenue563$6.1M in 2022
0$2.5M$5.0M$7.5M$10.0M2019: $0$020192020: $1.3M$1.3M20202021: $8.5M$8.5M2021+545%2022: $6.1M$6.1M2022−28%
Gross profit763$2.2M in 2022
0$1.0M$2.0M$3.0M$4.0M2019: $0$020192020: $401.5K$401.5K20202021: $3.8M$3.8M2021+842%2022: $2.2M$2.2M2022−41%
Operating income763-$4.1M in 2022+788% since 2019
-$6.0M-$4.0M-$2.0M02019: -$466.4K-$466.4K20192020: -$1.1M-$1.1M2020+128%2021: -$800.5K-$800.5K2021−25%2022: -$4.1M-$4.1M2022+417%
Net income864-$13.8M in 2022+137642% since 2018
-$15.0M-$10.0M-$5.0M02018: -$10.0K-$10.0K20182019: -$490.2K-$490.2K2019+4802%2020: -$1.2M-$1.2M2020+139%2021: -$2.0M-$2.0M2021+72%2022: -$13.8M-$13.8M2022+585%
Fiscal year20182019202020212022
Revenue$05$1.3M6$8.5M3$6.1M3
Cost of revenue$07$914.8K6$4.7M3$3.8M3
Gross profit$07$401.5K6$3.8M3$2.2M3
Selling, general and admin$56.2K7$110.5K6$897.3K3$1.5M3
Operating income-$466.4K7-$1.1M6-$800.5K3-$4.1M3
Interest$07$71.0K6$252.5K3$965.9K3
Income tax$07$06$03$03
Net income-$10.0K8-$490.2K8-$1.2M6-$2.0M4-$13.8M4

Compare BLOOMIOS, INC. with another company

Former names

  • XLR MEDICAL CORP.Sep 17, 2004 to Apr 15, 20212
  • RELAY MINES LTDMay 1, 2001 to Aug 30, 20042

Recent filings

  1. Mar 29, 20248-K
  2. Mar 8, 20248-K
  3. Nov 20, 202310-Q
  4. Nov 20, 20238-K
  5. Aug 21, 202310-Q
  6. Jun 26, 2023S-1/A
  7. Jun 20, 2023S-1
  8. May 18, 202310-Q
  9. Apr 17, 202310-K
  10. Jan 5, 20238-K/A
  11. Dec 2, 20223
  12. Nov 25, 20228-K
  13. Nov 21, 202210-Q
  14. Nov 14, 202210-K/A
  15. Oct 31, 20228-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1